Solicited Report

1. Feb 28, 2025

What Does the ‘Solicited Report’ Mean?

A solicited report refers to safety information collected in a systematic manner through organized data collection methods during clinical trials or post-marketing studies. These reports are typically obtained through structured questionnaires, patient diaries, or specific follow-up procedures designed to actively gather information about potential adverse events.

Solicited reports are distinct from spontaneous reports, which are voluntarily submitted by healthcare professionals or patients outside of organized data collection systems. The systematic nature of solicited reporting allows for more comprehensive and standardized safety data collection, helping researchers and regulators better assess the safety profile of investigational or marketed products.

Why Is the ‘Solicited Report’ Important in Clinical Research?

Solicited reports are crucial in clinical research as they provide a systematic and standardized approach to safety data collection. This methodology enhances the reliability and completeness of adverse event information, allowing researchers to more accurately assess the safety profile of investigational products.

The importance of solicited reports extends to regulatory compliance and decision-making processes. By utilizing structured data collection methods, clinical trials can meet regulatory requirements for comprehensive safety monitoring, ultimately contributing to more informed decisions about drug development and approval.

Good Practices and Procedures

1. Implement standardized questionnaires and electronic data capture systems to ensure consistent and efficient collection of solicited safety information across all study sites.
2. Establish clear timelines for solicited report submission and review, incorporating automated reminders to maximize compliance and data completeness.
3. Conduct regular training sessions for study personnel on recognizing and properly documenting adverse events to improve the quality and accuracy of solicited reports.
4. Utilize data visualization tools to identify trends and patterns in solicited safety data, facilitating early detection of potential safety signals.
5. Implement a quality control process, including periodic audits of solicited reports, to maintain data integrity and ensure adherence to good pharmacovigilance practices.

Related Terms

• Training Compliance
• Primary Endpoint
• Clinical Trial Monitor